Parkman Healthcare Partners’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,160	Closed	-$1.41M	–	95
2024 Q1	$1.41M	Buy	+20,160	New	+$1.41M	0.17%	90
2023 Q1	–	Sell	-25,000	Closed	-$1.15M	–	86
2022 Q4	$1.15M	Buy	+25,000	New	+$1.15M	0.31%	71